Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AbioCor patient dies, device operation blamed:

This article was originally published in Clinica

Executive Summary

The 13th patient to have received Abiomed's AbioCor heart replacement as part of a trial of the device has died of causes related to the device's operation. The Danvers, Massachusetts firm, which recently submitted a US marketing application for the device, said that together with the US hospital where the implantation was performed, it is investigating the situation and will release a report when an analysis has been completed. The patient had been supported by the device for 147 days. Candidates for the AbioCor clinical trial have a high probability of dying in less than 30 days.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059757

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel